Engineered immune cells under Long-Term watch: will the benefits last?
Disease control
Not yet recruiting
This study follows people who have already been treated with Senza5 CART5, a personalized cell therapy that uses a patient's own immune cells engineered to target cancer. The goal is to track long-term safety and how well the treatment continues to control the disease. Participan…
Sponsor: Vittoria Biotherapeutics • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC